Largest Clinical Trials companies in South Korea by Market Capitalization

This ranking features the largest 7 Clinical Trials companies in South Korea ranked by Market Capitalization, totalling a Market Capitalization of USD 2.25 B, for January 15, 2025.

South Korea

Clinical Trials
Market Capitalization
#
Name
Market Capitalization
 Reported Date
Stock Price
Change
 Price (30 days) Country
1
298380.KQ

ABL Bio Inc.

1

298380.KQ

USD 981.42 M

 Jan. 14, 2025 USD 21.07 1.40%

South Korea
2
039200.KQ

Oscotec Inc.

2

039200.KQ

USD 669.02 M

 Jan. 14, 2025 USD 17.25 0.74%

South Korea
3
226950.KQ

OliX Pharmaceuticals,Inc

3

226950.KQ

USD 186.22 M

 Jan. 14, 2025 USD 10.57 -0.48%

South Korea
4
095700.KQ

Genexine, Inc.

4

095700.KQ

USD 160.98 M

 Jan. 14, 2025 USD 3.70 0.18%

South Korea
5
011000.KS

GeneOne Life Science, Inc.

5

011000.KS

USD 130.12 M

 Jan. 14, 2025 USD 1.67 -1.86%

South Korea
6
235980.KQ

MedPacto, Inc.

6

235980.KQ

USD 99.85 M

 Jan. 14, 2025 USD 3.10 -1.75%

South Korea
7
229000.KQ

Gencurix Inc.

7

229000.KQ

USD 18.54 M

 Jan. 14, 2025 USD 1.17 -3.48%

South Korea
Frequently Asked Questions
  • Which Clinical Trials company in South Korea has the highest Market Capitalization ?

    The Clinical Trials company in South Korea with the highest Market Capitalization is ABL Bio Inc. (KOSDAQ: 298380.KQ) at USD 981.42 M.

  • Which Clinical Trials company in South Korea has the lowest Market Capitalization ?

    The Clinical Trials company in South Korea with the lowest Market Capitalization is Gencurix Inc. (KOSDAQ: 229000.KQ) at USD 18.54 M.